Medical Oncology

Doç. Dr. İlkay Gültürk

Doctor and researcher İstanbul Eğitim Araştırma Hastanesi İstanbul
Breast NeoplasmsCarcinoma, Renal CellKidney NeoplasmsProstatic NeoplasmsPancreatic NeoplasmsMelanoma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 8 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Carcinoma, Renal Cell 3 publications
  • Kidney Neoplasms 3 publications
  • Prostatic Neoplasms 2 publications
  • Pancreatic Neoplasms 2 publications
  • Melanoma 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • Institutionİstanbul Eğitim Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 8 publications · Model version —From source
  • Publications52 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0003-1998-3150ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://istanbuleah.saglik.gov.tr/TR-1039967/doktorlar.html#ilkay-gulturksaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

52 publications

  1. Bone Pain Is Associated with Short Radiographic Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103968 PMID 42194929 Open-access full textSource: OpenAlex

  2. Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

    Cancers, 2026

    DOI 10.3390/cancers18142302 PMID 42512369 Open-access full textSource: ORCID

  3. Association between obesity and outcomes of first-line CDK4/6 inhibitor therapy in metastatic breast cancer: a multicenter real-world study

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-58205-7 PMID 42304044 Open-access full textSource: OpenAlex

  4. Kaposi Sarcoma Presenting as Hemophagocytic Lymphohistiocytosis Mimicking Infection and Lymphoma: A Diagnostic Challenge

    Cureus, 2026

    DOI 10.7759/cureus.105780 PMID 42037832 Open-access full textSource: OpenAlex

  5. Bone Pain Is Associated with Short Radiologic-Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer

    2026

    DOI 10.20944/preprints202604.1309.v1 Open-access full textSource: ORCID

  6. Association of Pretreatment IronMLR and ANR With Pathological Response Following Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

    SSRN Electronic Journal, 2026

    DOI 10.2139/ssrn.7100220 Open-access full textSource: ORCID

  7. The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer

    The Prostate, 2026

    DOI 10.1002/pros.70185 PMID 42018584 Open-access full textSource: ORCID

  8. Association of Pretreatment ANR and IronMLR With Pathological Response Following Neoadjuvant Chemotherapy in Breast Cancer

    Breast Cancer Targets and Therapy, 2026

    DOI 10.2147/bctt.s623894 PMID 42677318 Open-access full textSource: OpenAlex

  9. A multi-center case-control study on osteoporosis risk in cancer patients receiving chemotherapy.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.12033 Source: OpenAlex

  10. A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-09973-x PMID 41225034 1 citation (Europe PMC) Source: OpenAlex

View all 52 publications